Title: Innovations of Shu-Ping Chen in Pharmaceutical Science
Introduction
Shu-Ping Chen is an accomplished inventor based in Singapore, SG. He has made significant contributions to the field of pharmaceutical science, particularly in the development of novel crystalline forms of irinotecan hydrochloride. His work aims to enhance the treatment options for metastatic carcinoma of the colon or rectum.
Latest Patents
Shu-Ping Chen holds a patent for "Novel Crystal Forms Of Irinotecan Hydrochloride." This invention provides for novel crystalline forms of irinotecan hydrochloride, along with processes for their preparation. The patent also includes pharmaceutical compositions containing these novel forms and methods for treating metastatic carcinoma of the colon or rectum using the same.
Career Highlights
Shu-Ping Chen is currently employed at Scinopharm Singapore Pte Ltd., where he continues to innovate in the pharmaceutical sector. His work focuses on improving drug formulations and enhancing therapeutic efficacy.
Collaborations
Shu-Ping Chen collaborates with Piin-Jye Harn, contributing to advancements in their field through shared expertise and innovative approaches.
Conclusion
Shu-Ping Chen's contributions to pharmaceutical science, particularly through his patent on irinotecan hydrochloride, highlight his role as a key innovator in the industry. His ongoing work at Scinopharm Singapore Pte Ltd. continues to pave the way for advancements in cancer treatment.